Cleveland Clinic Lou Ruvo Center for Brain Health Opens for Business
LAS VEGAS, July 13 /PRNewswire/ -- The Cleveland Clinic Lou Ruvo Center for Brain Health welcomes its first patients today, opening the doors to an architectural gem and a highly touted model of patient-focused care. The Cleveland Clinic Lou Ruvo Center fo...More than $10 Million Raised for the Fight Against Lou Gehrig's Disease
Baseball Great Curt Schilling and Wife Shonda Enter The ALS Association's Hall of Fame, Receive Award Calabasas Hills, CA (Vocus) May 14, 2009 -- The ALS Association has inducted former Major League Baseball pitcher Curt Schilling and his wife Shonda into the organizati...Human stem cells provide a new model for Lou Gehrig's disease
February 23, 2009, Cambridge, UK Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a devastating condition in which motor neuron degeneration causes progressive loss of movement and muscle tone, leading to death. Overcoming the limited success of previous models, a re...Spinal fluid proteins signal Lou Gehrig's disease
High levels of certain proteins in the spinal fluid could signal the onset of Lou Gehrig's disease, according to researchers. The discovery of these biomarkers may lead to diagnostic kits for early diagnosis, accurately measuring the progression of the disease and monitoring the effects of treatme...ALS TDI and Asklepios to Develop New Therapeutic Delivery Options for Treating Lou Gehrig's Disease
Collaboration to evaluate gene delivery vectors for ALS CAMBRIDGE, Mass. and CHAPEL HILL, N.C., Jan. 20 /PRNewswire-USNewswire/ -- ALS Therapy Development Institute (ALS TDI) and Asklepios BioPharmaceutical, Inc. announced today their collaboration aimed at developing a panel of viral vectors...Data mining detects signs of Lou Gehrig's disease in gene carriers long before symptoms appear
WASHINGTON Inspired by the use of microarray chips that look for gene combinations, psychologists are using "pattern array" software to spot movements in rats that might help them predict diseases such as Lou Gehrig's syndrome. A report in the August issue of Behavioral Neuroscience, publish...Scientists ID 'Jekyll-Hyde' Protein in Lou Gehrig's Disease
Gene mutations cause superoxide dismutase to clump up in motor neurons TUESDAY, July 29 (HealthDay News) -- A protein dysfunction could help drive amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, according to a study by researchers at Brandeis University and Ha...ALS TDI Completes Gene Expression Profile of Lou Gehrig's Disease in Mice
Largest Target-Discovery Program Aimed at New Treatments for Fatal Disease CAMBRIDGE, Mass., Oct. 2 /PRNewswire/ -- The ALS Therapy Development Institute (ALS TDI) today announced that it has completed the first phase of a comprehensive gene-expression database for ALS with the profiling of the...Progress Against Malaria and Other Infectious Diseases Among Highlights at Annual Vaccine Conference
... the International Vaccine Institute in Seoul, Korea, will deliver the Mary lou Clements-Mann Memorial Lecture on Vaccine Sciences at 8:00 a.m. on Tuesday....ns more than two million people every year. The lecture is named after Mary lou Clements-Mann, an immunologist at Johns Hopkins University who was killed...Neuralstem Licenses Cleveland Clinic Spinal Cord Injection Technology
...icensed today will help us to meet those goals." Neuralstem will use this technology in its clinical trial for ALS (Amytrophic Lateral Sclerosis, or lou Gehrig's disease). The company anticipates filing its IND (Investigational New Drug) application with the FDA for the ALS trial in the next few weeks,...Annual Conference on Vaccine Research to Highlight Not Only Health Benefits But Also Economic Gains
...rted by unrestricted educational grants from Merck & Co, Inc. Dr. Barton F. Haynes, director of the Duke Human Vaccine Institute, will give the Mary lou Clements-Mann Memorial Lecture on Vaccine Sciences. On Wednesday, the conference will announce this year's winner of the Maurice R. Hilleman Early Sta...Insmed Provides Update on Follow-On Biologics and IPLEX(TM) Programs
...e to severe primary IGF-I deficiency, is currently being investigated in Myotonic Muscular Dystrophy (MMD) and Amyotrophic Lateral Sclerosis (ALS), or lou Gehrig's disease. A Phase 2 trial of IPLEX(TM) in MMD is on-going and a substantial portion of the external costs associated with the study are expe...Neptune Industries Reports Favorable Phase II Trial Results on Ento- Protein(TM)
...007. Phase II trials were a collaborative effort between the Departments of Entomology, Wildlife and Fisheries, and Food Science and Technology. Dr. lou D'Abramo, Professor, Department of Wildlife and Fisheries at Mississippi State stated, "In the recent feeding trial, the Ento-Protein(TM) replaced fis...Caffeine appears to be beneficial in males -- but not females -- with Lou Gehrig's disease
NEW ORLEANSAmyotrophic lateral sclerosis (ALS) is a fatal disease that damages key neurons in the brain and spinal cord. The disease causes progressive paralysis of voluntary muscles and often death within five years of symptoms. Although ALS (Lou Gehrig's disease) was discovered over a century ag...Caffeine appears to be beneficial in males -- but not females -- with Lou Gehrig's disease
NEW ORLEANSAmyotrophic lateral sclerosis (ALS) is a fatal disease that damages key neurons in the brain and spinal cord. The disease causes progressive paralysis of voluntary muscles and often death within five years of symptoms. Although ALS (Lou Gehrig's disease) was discovered over a century ag...Researchers genetically link Lou Gehrig's disease in humans to dog disease
COLUMBIA, Mo. An incurable, paralyzing disease in humans is now genetically linked to a similar disease in dogs. Researchers from the University of Missouri and the Broad Institute have found that the genetic mutation responsible for degenerative myelopathy (DM) in dogs is the same mutation that c...Gene hunters close in on Lou Gehrig’s disease
In the first genome-wide search for the genetic roots of the most common form of amyotrophic lateral sclerosis (ALS), Johns Hopkins scientists have newly identified 34 unique variations in the human genetic code among 276 unrelated subjects with ALS. The 34 so-called single nucleotide polymorphis...Human stem cells delay start of Lou Gehrig's disease in rats
Researchers at Johns Hopkins have shown that transplanting human stem cells into spinal cords of rats bred to duplicate Lou Gehrig's disease delays the start of nerve cell damage typical of the disease and slightly prolongs life. The grafted stem cells develop into nerve cells that make substantial...Variations in detoxifying genes linked to Lou Gehrig's disease
Genetic variations in three enzymes that detoxify insecticides and nerve gas agents as well as metabolize cholesterol-lowering statin drugs may be a risk factor for developing sporadic amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease), and possibly responsible for a reported twofold incr...'Show me the money!' MDA greenlights grants
...e treatments of muscular dystrophy, amyotrophic lateral sclerosis (ALS), or lou Gehrig's disease, and spinal muscular atrophy. It also served as the basis ...e blood-brain barrier contribute to amyotrophic lateral sclerosis (ALS), or lou Gehrig's disease. Ilieva hopes to find a way to use genetic therapy to trea...Reading the brain without poking it
...ctrodes someday might be placed over the brain's speech center in patients who cannot communicate because they are paralyzed by spinal injury, stroke, lou Gehrig's disease or other disorders, he adds. The electrodes would send speech signals to a computer that would covert the thoughts to audible words. ...Novel handheld device detects anthrax with outstanding accuracy and reliability
...nd the sample is typically destroyed during testing. The new data will be presented on June 26, 2009 at Biodetection Technologies 2009 by Professor lou Reinisch, an inventor of the Ceeker technology and Professor of Physics and Department Head at Jacksonville State University in Alabama. Prof. Reinis...UMMS researchers isolate first 'neuroprotective' gene in patients with amyotrophic lateral sclerosis
... WORCESTER, Mass. A genetic variant that substantially improves survival of individuals with amyotrophic lateral sclerosis (ALS), also known as lou Gehrig's disease, has been indentified by a consortium of researchers led by John Landers, PhD, Associate Professor of Neurology and Robert Brown, MD,...Campaign to Increase the Awareness and Understanding of Lou Gehrig's Disease Reaches 22 U.S. States
Non-Profit Biotech Calls on the Entire ALS Community to Join a Nationwide Network of Independence Day Events CAMBRIDGE, Mass., May 18 /PRNewswire-USNewswire/ -- The ALS Therapy Development Institute (ALS TDI) announced its BBQ For ALS Awareness , is a national initiative designed to increas...Novel handheld device detects anthrax with outstanding accuracy and reliability
...nd the sample is typically destroyed during testing. The new data will be presented on June 26, 2009 at Biodetection Technologies 2009 by Professor lou Reinisch, an inventor of the Ceeker technology and Professor of Physics and Department Head at Jacksonville State University in Alabama. Prof. Reinis...Bay Area Youth to Represent ALS Patients at Giants' and Angels' Baseball Games on July 4th
...e awareness of amyotrophic lateral scleroses (ALS, lou Gehrig's disease) a neurodegenerative disease of w... on July 4, 2009, which is the 70th anniversary of lou Gehrig's famous farewell speech at Yankee Stadium.... will take part in a pre-game celebration honoring lou Gehrig and ALS patients that are currently battlin...Insmed Announces First Quarter 2009 Financial Results
...FDA announced that it would allow Insmed to provide access to IPLEX(TM) for investigational use in patients with Amyotrophic Lateral Sclerosis (ALS or lou Gehrig's disease). Insmed will conduct a controlled clinical trial under an Investigational New Drug application; Announced the signing o...Roche Madison Moves to New Facility
...s leading pharmaceutical companies," he added. "The scientific efforts in Madison are complementary to those at our other global RNA sites," said lou Renzetti, Ph.D., global head, RNA Therapeutics at Roche. "Our colleagues in Madison have a lot to offer in terms of their expertise, which will signif...University of Maryland Announces Finalists for $75K Business Plan Competition
... Technology Development Corporation; Paul Allenza, director, Biotechnology Research and Education Program; entrepreneur Bill Bellows; bio-entrepreneur lou Cantolupo; Warren Citrin, co-founder and board member, Gloto Corp., co-founder, Solipsys Corporation; Rob Cohen; Craig Dye, member, board of advisors,...